69.89

3.14% 2.13

Dopo l'orario di chiusura: 69.89

Edwards Lifesciences Corp (EW)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché EW Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$67.76

Aprire:

$67.63

Volume 24 ore:

6.96M

Relative Volume:

1.19

Capitalizzazione di mercato:

$40.52B

Reddito:

$6.60B

Utile/perdita netta:

$4.16B

Rapporto P/E:

29.87

EPS:

2.34

Flusso di cassa netto:

$490.10M

1 W Prestazione:

+4.78%

1M Prestazione:

-0.54%

6M Prestazione:

-21.60%

1 anno Prestazione:

+4.47%

Intervallo 1D:

$67.58

$71.08

Intervallo di 1 settimana:

$64.89

$71.08

Portata 52W:

$58.93

$96.12

Edwards Lifesciences Corp Stock (EW) Company Profile

Nome

Edwards Lifesciences Corp

Settore

Healthcare (1196)

Industria

Medical Devices (153)

Telefono

(949) 250-2500

Indirizzo

ONE EDWARDS WAY, IRVINE, CA

Dipendente

19,800

Cinguettio

@edwardslifesci

Prossima data di guadagno

2024-10-24

Ultimi documenti SEC

EW's Discussions on Twitter

Confronta EW con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EW	69.89	40.52B	6.60B	4.16B	490.10M	2.34
ABT	117.36	202.64B	41.22B	5.77B	6.49B	2.94
SYK	389.40	150.72B	21.97B	3.59B	3.21B	6.74
BSX	90.45	133.82B	15.91B	1.79B	1.89B	0.82
MDT	87.59	112.98B	32.58B	3.93B	5.15B	2.71

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-11	Ripresa	Morgan Stanley	Equal-Weight
2024-09-18	Downgrade	Jefferies	Buy → Hold
2024-07-31	Aggiornamento	Daiwa Securities	Neutral → Outperform
2024-07-29	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2024-07-25	Downgrade	BofA Securities	Buy → Neutral
2024-07-25	Downgrade	JP Morgan	Overweight → Neutral
2024-07-25	Downgrade	Robert W. Baird	Outperform → Neutral
2024-07-25	Downgrade	TD Cowen	Buy → Hold
2024-07-25	Downgrade	Truist	Buy → Hold
2024-05-30	Iniziato	Goldman	Buy
2024-05-22	Aggiornamento	Citigroup	Neutral → Buy
2024-05-14	Aggiornamento	Deutsche Bank	Hold → Buy
2024-03-07	Aggiornamento	BofA Securities	Neutral → Buy
2024-02-02	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-01-04	Downgrade	Evercore ISI	Outperform → In-line
2023-12-11	Downgrade	Citigroup	Buy → Neutral
2023-11-28	Downgrade	Wolfe Research	Peer Perform → Underperform
2023-09-26	Aggiornamento	Oppenheimer	Perform → Outperform
2023-07-19	Iniziato	Robert W. Baird	Outperform
2023-05-30	Ripresa	Morgan Stanley	Overweight
2023-03-29	Iniziato	UBS	Neutral
2023-03-08	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-02-06	Downgrade	Raymond James	Outperform → Mkt Perform
2023-01-31	Downgrade	Bernstein	Outperform → Underperform
2023-01-30	Downgrade	Piper Sandler	Overweight → Neutral
2022-12-06	Downgrade	Stifel	Buy → Hold
2022-10-28	Downgrade	Oppenheimer	Outperform → Perform
2022-10-26	Iniziato	Mizuho	Buy
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Buy
2022-07-29	Downgrade	Canaccord Genuity	Buy → Hold
2022-04-13	Iniziato	Truist	Buy
2022-04-06	Iniziato	Wolfe Research	Outperform
2022-03-16	Aggiornamento	Bernstein	Mkt Perform → Outperform
2022-03-02	Ripresa	BofA Securities	Neutral
2022-02-02	Aggiornamento	UBS	Neutral → Buy
2022-01-27	Reiterato	Citigroup	Buy
2022-01-27	Reiterato	Evercore ISI	Outperform
2022-01-27	Reiterato	Raymond James	Outperform
2022-01-27	Reiterato	Stifel	Buy
2022-01-27	Reiterato	UBS	Neutral
2021-12-17	Aggiornamento	JP Morgan	Neutral → Overweight
2021-12-15	Aggiornamento	Citigroup	Neutral → Buy
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-12-06	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2021-07-30	Reiterato	Canaccord Genuity	Buy
2021-07-30	Reiterato	Deutsche Bank	Hold
2021-07-30	Reiterato	Jefferies	Buy
2021-07-30	Reiterato	Morgan Stanley	Overweight
2021-07-30	Reiterato	Oppenheimer	Outperform
2021-07-30	Reiterato	Stifel	Buy
2021-07-30	Reiterato	UBS	Neutral
2021-07-30	Reiterato	Wells Fargo	Equal Weight
2021-05-25	Iniziato	Barclays	Overweight
2021-04-15	Iniziato	Atlantic Equities	Neutral
2021-04-05	Aggiornamento	Evercore ISI	In-line → Outperform
2020-12-16	Downgrade	Citigroup	Buy → Neutral
2020-12-11	Reiterato	Canaccord Genuity	Buy
2020-09-11	Iniziato	Wolfe Research	Underperform
2020-04-28	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-04-17	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Neutral
2020-02-06	Ripresa	BTIG Research	Neutral
2020-01-10	Iniziato	Oppenheimer	Outperform
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-10-24	Reiterato	Canaccord Genuity	Buy
2019-09-23	Iniziato	Piper Jaffray	Overweight
2019-07-24	Reiterato	BofA/Merrill	Buy
2019-03-18	Reiterato	Canaccord Genuity	Buy
2019-01-18	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-01-03	Iniziato	Deutsche Bank	Hold
2018-11-28	Iniziato	UBS	Neutral
2018-10-16	Iniziato	Barclays	Underweight
2018-10-02	Downgrade	BofA/Merrill	Buy → Neutral
2018-10-02	Downgrade	Guggenheim	Buy → Neutral

Mostra tutto

Edwards Lifesciences Corp Borsa (EW) Ultime notizie

12:02 PM

Edwards Lifesciences Corporation Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationEW - Marketscreener.com

12:02 PM

09:13 AM

Edwards Lifesciences wins Meril injunction as pro-patentee decisions continue to flow from UPC - IAM

09:13 AM

08:35 AM

Edwards deals a severe blow to Meril with regular advisors - JUVE Patent

08:35 AM

Nov 17, 2024

Kessler Topaz Meltzer & Check, LLP Notifies Edwards Lifesciences Corporation Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit - GlobeNewswire Inc.

Nov 17, 2024

S&CO Inc. Has $4.06 Million Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Nov 17, 2024

2024-11-17 | DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation | NYSE:EW | Press Release - Stockhouse Publishing

Nov 17, 2024

Nov 16, 2024

Edwards Lifesciences quarterly net falls on charge - Reuters.com

Nov 16, 2024

Ipswich Investment Management Co. Inc. Cuts Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Edwards Lifesciences Corp Class Action: Lead Plaintiff Deadline is 12/13/24; Contact Robbins LLP for Information - Benzinga

Nov 15, 2024

Edwards Lifesciences Corp Class Action: Lead Plaintiff Deadline is 12/13/24; Contact Robbins LLP for - EIN News

Nov 15, 2024

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Nov 15, 2024

EW COURT REPORT: A Class Action has been Filed Against Edwards Lifesciences, Investors are Urged to Contact BFA Law by December 13 Deadline - Newsfile

Nov 15, 2024

Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion Of Market CapitalizationHagens Berman - Marketscreener.com

Nov 15, 2024

Huntington National Bank Lowers Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Nov 15, 2024

KBC Group NV Buys 104,499 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Nov 15, 2024

Finansavisen - Finansavisen

Nov 15, 2024

Nov 14, 2024

EW Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Edwards Lifesciences Corporation Investors to Contact the Firm About Securities Fraud Class Action Lawsuit - Markets Insider

Nov 14, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation - Marketscreener.com

Nov 14, 2024